Data as of Jan 30
| -0.60 / -6.80%|
The 3 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a -14.84% decrease from the last price of 8.22.
The current consensus among 5 polled investment analysts is to Hold stock in ChemoCentryx Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.